anacetrapib News
Most Popular anacetrapib Story
Anacetrapib - 15 top blockbuster contenders
The drug: AnacetrapibThe disease: CardiovascularThe developer: MerckPeak projections: $10 billion-plus (David Maris, a Credit Agricole Securities analyst) Before Roche goes collecting any $10 billion Read more...
Latest Headlines
- November 10, 2011
- October 25, 2011
- November 10, 2010
- November 18, 2009
- October 5, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
